Company
Investment-firm
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
IPO status
Contacts
Similar Companies320
TardiMed Sciences
TardiMed Sciences is a life sciences investment firm.
Sector
Subsector
Advent Life Sciences
Advent Life Sciences is a leading European venture team investing in life sciences businesses.
Sector
Subsector
Location
count Of Investments
count Of Exists
Nan Fung Life Sciences
Nan Fung Life Sciences is a global life sciences investment platform backed by the Nan Fung Group.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Medicxi
Medicxi is a life sciences-focused investment firm with a global presence.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Financials
Investments8
CalciMedica
CalciMedica is developing drugs that target CRAC channels for the treatment of inflammatory and autoimmune diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
CalciMedica
CalciMedica is developing drugs that target CRAC channels for the treatment of inflammatory and autoimmune diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
JenaValve Technology
JenaValve Technology develops transcatheter aortic valve implantation (TAVI) systems.
Sector
Subsector
Keywords
Location
total rounds
total raised
Co-Investors
Exits2
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company that develops cancer therapies using a drug ratio technology platform.
Sector
Subsector
Keywords
Location
total rounds
total raised
Invuity
Invuity develops illumination and visualization products for minimally invasive surgical field applications.
Sector
Subsector
Keywords
Location
total rounds
total raised
People
Founders1
Eric Roberts
Mr. Roberts has more than 27 years of experience in the life sciences and finance industries. In 2012, he co-founded Valence Advantage Life Sciences. Prior to Valence Advantage, Mr. Roberts managed Caxton Advantage Venture Partners which he co-founded in 2004. Previously, he was Managing Director and Co-Head of the Global Healthcare Investment Banking Group at Lehman Brothers. He also served as a member of the Investment Banking Management Committee and as a member of the screening committee for the Lehman Brothers Healthcare Venture Capital Fund. He was also a Managing Director, Partner and founder of the Life Sciences Department at Dillon, Read & Co. Inc. which was ultimately merged into UBS. At UBS, he ran the life sciences investment banking team. In addition, Mr. Roberts worked at Citicorp in the Citicorp Venture Capital (CVC) group before Dillon Read. He has served on the boards of several life sciences companies and charitable organizations. Mr. Roberts holds a B.S. in Economics from the Wharton School of the University of Pennsylvania.
current job
Eric Roberts